Gabriela Demidowicz
Research Subjects
Gabriela Demidowicz has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Natalia Trąbka
Medical Center ANAMED 21-100 Lubartów, Kolejowa 5, Poland
12 shared publications - Klaudia Kowalczyk
Pharmacy “Centrum Zdrowia”, Grunwaldzka 21 street, 72-600 Świnoujście, Poland
11 shared publications - Nina Lasota
Private Health Center “Medicus”, Dmowskiego 37, 97-300 Piotrków Trybunalski
11 shared publications - Julia Czarnota
Franciszek Raszeja Memorial Municipal Hospital in Poznań Mickiewicza 2 street, 60-834 Poznań
7 shared publications - Katarzyna Cichoń
Independent Public Clinical Hospital No. 4 in Lublin. Jaczewskiego 8 street, 20-954 Lublin
7 shared publications - Maciej Lambach
Kardynał Stefan Wyszyński Province Specialist Hospital in Lublin, Kraśnicka 100 avenue, 20-718 Lublin, Poland
7 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by MDPI AG in Preprints.org
Nanotechnology Systems in Drug Delivery to the Anterior Segment of the Eye—A Narrative Review of the Latest Preclinical Research Results
Background: Eye diseases represent a significant public health problem. The effectiveness of ophthalmic pharmacotherapy largely depends on efficient drug delivery to the eye tissues. Conventional eye drops exhibit low bioavailability due to anatomical and physiological barriers. Nanotechnology offers novel strategies to enhance drug penetration, retention, and controlled release within the anterior segment of the eye. This study aimed to systematically analyze preclinical research on the use of nanocarriers in drug delivery to the anterior segment. Methods: A literature review was conducted using PubMed, Scopus, and Google Scholar databases, covering English-language publications from 2019 to 2025. Preclinical studies evaluating nanocarriers for the treatment of anterior segment eye diseases and available in full text were included. Results: The analyzed studies indicate that nanocarriers, including solid lipid nanoparticles, nanostructured lipid carriers, nanomicelles, and polymeric nanoparticles, enhance drug bioavailability by improving mucoadhesion, facilitating penetration through the corneal epithelium, and prolonging ocular surface retention time. Key physicochemical parameters include small particle size, low polydispersity index, appropriate zeta potential, and high encapsulation efficiency. Preclinical models demonstrated improved therapeutic outcomes, including greater intraocular pressure reduction in glaucoma, increased tear production in dry eye syndrome, and enhanced anti-inflammatory and antifungal effects compared with conventional preparations. Conclusions: Nanotechnology-based drug delivery systems represent a promising strategy for improving therapy of the anterior segment eye diseases. However, further preclinical and clinical studies are required to confirm their clinical applicability.
- 31 March 2026
- Published by MDPI AG in Preprints.org
Open AccessNanotechnology Systems in Drug Delivery to the Anterior Segment of the Eye—A Narrative Review of the Latest Preclinical Research Results
Background: Eye diseases represent a significant public health problem. The effectiveness of ophthalmic pharmacotherapy largely depends on efficient drug delivery to the eye tissues. Conventional eye drops exhibit low bioavailability due to anatomical and physiological barriers. Nanotechnology offers novel strategies to enhance drug penetration, retention, and controlled release within the anterior segment of the eye. This study aimed to systematically analyze preclinical research on the use of nanocarriers in drug delivery to the anterior segment. Methods: A literature review was conducted using PubMed, Scopus, and Google Scholar databases, covering English-language publications from 2019 to 2025. Preclinical studies evaluating nanocarriers for the treatment of anterior segment eye diseases and available in full text were included. Results: The analyzed studies indicate that nanocarriers, including solid lipid nanoparticles, nanostructured lipid carriers, nanomicelles, and polymeric nanoparticles, enhance drug bioavailability by improving mucoadhesion, facilitating penetration through the corneal epithelium, and prolonging ocular surface retention time. Key physicochemical parameters include small particle size, low polydispersity index, appropriate zeta potential, and high encapsulation efficiency. Preclinical models demonstrated improved therapeutic outcomes, including greater intraocular pressure reduction in glaucoma, increased tear production in dry eye syndrome, and enhanced anti-inflammatory and antifungal effects compared with conventional preparations. Conclusions: Nanotechnology-based drug delivery systems represent a promising strategy for improving therapy of the anterior segment eye diseases. However, further preclinical and clinical studies are required to confirm their clinical applicability.
- Open Access
- 15 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 60, 104-117
Combined Anticancer Therapy for Prostate Cancer - Literature Review
Prostate cancers represent a significant health problem, and their etiology is complex and multifaceted. It is estimated that in 2018, 1.3 million new cases and 359,000 deaths due to prostate cancer were diagnosed. They constitute the second most common group of cancers and the fifth most common cause of cancer-related deaths in men worldwide. The present study encompasses a literature review aimed at conducting an analysis of the potential of combined anticancer therapy as a prospective method for enhancing treatment efficacy, minimizing side effects, and improving long-term survival outcomes for prostate cancer patients. Combinations of compounds such as sunitinib with docetaxel, carboplatin with paclitaxel, estramustine or flutamide with luteinizing hormone-releasing hormone agonists, as well as docetaxel in conjunction with dexamethasone and octreotide, have demonstrated synergistic effects and an augmentation of therapeutic effectiveness. It is noteworthy to emphasize the potential enhancement of docetaxel's anticancer activity with concurrent administration of dexamethasone and octreotide, as well as combined therapy involving docetaxel, prednisone, and curcumin.
- 15 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 60, 104-117
Open AccessCombined Anticancer Therapy for Prostate Cancer - Literature Review
Prostate cancers represent a significant health problem, and their etiology is complex and multifaceted. It is estimated that in 2018, 1.3 million new cases and 359,000 deaths due to prostate cancer were diagnosed. They constitute the second most common group of cancers and the fifth most common cause of cancer-related deaths in men worldwide. The present study encompasses a literature review aimed at conducting an analysis of the potential of combined anticancer therapy as a prospective method for enhancing treatment efficacy, minimizing side effects, and improving long-term survival outcomes for prostate cancer patients. Combinations of compounds such as sunitinib with docetaxel, carboplatin with paclitaxel, estramustine or flutamide with luteinizing hormone-releasing hormone agonists, as well as docetaxel in conjunction with dexamethasone and octreotide, have demonstrated synergistic effects and an augmentation of therapeutic effectiveness. It is noteworthy to emphasize the potential enhancement of docetaxel's anticancer activity with concurrent administration of dexamethasone and octreotide, as well as combined therapy involving docetaxel, prednisone, and curcumin.
- Open Access
- 15 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 60, 90-103
Navigating the landscape of Postpartum Depression: a comprehensive review
Introduction and purpose: The joyous occasion of childbirth is often overshadowed by the prevalence of postpartum depression (PPD), a complex mental health condition affecting mothers globally. This paper reviews the current state of knowledge on PPD, exploring its frequency, risk factors, pathogenesis, symptoms, and impact on maternal and child health. Description of the State of Knowledge: Recent studies indicate an alarming increase in PPD rates, with notable racial and socioeconomic disparities. Symptoms of PPD, ranging from mild to severe include mood disturbances, cognitive impairments, and self-harm ideation. The repercussions extend beyond the postpartum period, affecting long-term child development, breastfeeding practices, and the mother-infant bond. Advancements in screening tools, particularly the Edinburgh Postnatal Depression Scale (EPDS), have facilitated early detection. However, creating an environment conducive to open communication about mental health remains a significant challenge. Interventions for PPD include psychotherapeutic approaches, pharmacological interventions, and complementary therapies. Brexanolone, the first FDA-approved drug for PPD, represents a significant breakthrough. Community-based and peer support programs, alongside a multidisciplinary approach involving healthcare professionals and support networks, have shown promise in alleviating PPD symptoms. Summary: In conclusion, PPD remains a substantial public health concern. Increased awareness of its multifaceted nature has led to improved screening, diagnosis, and intervention strategies. Ongoing dialogue, supportive environments, and refined treatments are essential for enhancing the well-being of both mothers and their infants in the postpartum period.
- 15 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 60, 90-103
Open AccessNavigating the landscape of Postpartum Depression: a comprehensive review
Introduction and purpose: The joyous occasion of childbirth is often overshadowed by the prevalence of postpartum depression (PPD), a complex mental health condition affecting mothers globally. This paper reviews the current state of knowledge on PPD, exploring its frequency, risk factors, pathogenesis, symptoms, and impact on maternal and child health. Description of the State of Knowledge: Recent studies indicate an alarming increase in PPD rates, with notable racial and socioeconomic disparities. Symptoms of PPD, ranging from mild to severe include mood disturbances, cognitive impairments, and self-harm ideation. The repercussions extend beyond the postpartum period, affecting long-term child development, breastfeeding practices, and the mother-infant bond. Advancements in screening tools, particularly the Edinburgh Postnatal Depression Scale (EPDS), have facilitated early detection. However, creating an environment conducive to open communication about mental health remains a significant challenge. Interventions for PPD include psychotherapeutic approaches, pharmacological interventions, and complementary therapies. Brexanolone, the first FDA-approved drug for PPD, represents a significant breakthrough. Community-based and peer support programs, alongside a multidisciplinary approach involving healthcare professionals and support networks, have shown promise in alleviating PPD symptoms. Summary: In conclusion, PPD remains a substantial public health concern. Increased awareness of its multifaceted nature has led to improved screening, diagnosis, and intervention strategies. Ongoing dialogue, supportive environments, and refined treatments are essential for enhancing the well-being of both mothers and their infants in the postpartum period.
- Open Access
- 13 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 59, 54-72
Atopic dermatitis - itchy problem of children and adults
Atopic dermatitis is a chronic inflammatory disease with recurrent exacerbations, persistent itching, erythema, dry skin due to damage to the epidermal barrier, and staphylococcal infections. The causative factors are mutations in the gene encoding filaggrin, dysregulation of the immune system, changes in the skin microbiome and lipids in the stratum corneum and deficiency of antimicrobial peptides AMPs. The disease mainly affects children, causing a significant deterioration in the quality of life, and its first symptoms occur in approximately 90% before the age of 5. Lesions most often appear on the bends of elbows and knees, on the face and neck, but may also affect the skin of the entire body (erythroderma). The location of the eruptions depends on age. Atopic dermatitis is the result of complex genetic, epigenetic, environmental and immunological interactions with a coexisting epidermal barrier defect. The disease is diagnosed based on the Hanifin and Rajka criteria. Treatment of atopic dermatitis is symptomatic and selected individually. They include the elimination of provoking factors, care of the epidermal barrier, and anti-inflammatory and anti-pruritic therapy.
- 13 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 59, 54-72
Open AccessAtopic dermatitis - itchy problem of children and adults
Atopic dermatitis is a chronic inflammatory disease with recurrent exacerbations, persistent itching, erythema, dry skin due to damage to the epidermal barrier, and staphylococcal infections. The causative factors are mutations in the gene encoding filaggrin, dysregulation of the immune system, changes in the skin microbiome and lipids in the stratum corneum and deficiency of antimicrobial peptides AMPs. The disease mainly affects children, causing a significant deterioration in the quality of life, and its first symptoms occur in approximately 90% before the age of 5. Lesions most often appear on the bends of elbows and knees, on the face and neck, but may also affect the skin of the entire body (erythroderma). The location of the eruptions depends on age. Atopic dermatitis is the result of complex genetic, epigenetic, environmental and immunological interactions with a coexisting epidermal barrier defect. The disease is diagnosed based on the Hanifin and Rajka criteria. Treatment of atopic dermatitis is symptomatic and selected individually. They include the elimination of provoking factors, care of the epidermal barrier, and anti-inflammatory and anti-pruritic therapy.
- Open Access
- 13 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 58, 210-224
Diogenes syndrome - causes and treatment of pathological hoarding and self neglect
Introduction Diogenes syndrome is a behavioral disorder typically described in physically neglected people living in extreme poverty, unsanitary conditions and self-imposed isolation, who often refuse outside help and tend to accumulate unusual objects. This syndrome is gaining increasing attention in the world of neurology and psychiatry. The aim of the study To summarize current knowledge on the causes of Diogenes syndrome, its characteristics and treatment. Material and methods The search of the Pubmed and Google Scholar database was carried out using keywords, in order to find the latest publications. Summary Diogenes syndrome is a complex disease that will affect an increasing number of elderly people as the population ages. There is a lack of extensive research to create clear diagnostic criteria, classification and treatment for Diogenes syndrome. The creation of a disease entity would enable earlier diagnosis and help patients.
- 13 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 58, 210-224
Open AccessDiogenes syndrome - causes and treatment of pathological hoarding and self neglect
Introduction Diogenes syndrome is a behavioral disorder typically described in physically neglected people living in extreme poverty, unsanitary conditions and self-imposed isolation, who often refuse outside help and tend to accumulate unusual objects. This syndrome is gaining increasing attention in the world of neurology and psychiatry. The aim of the study To summarize current knowledge on the causes of Diogenes syndrome, its characteristics and treatment. Material and methods The search of the Pubmed and Google Scholar database was carried out using keywords, in order to find the latest publications. Summary Diogenes syndrome is a complex disease that will affect an increasing number of elderly people as the population ages. There is a lack of extensive research to create clear diagnostic criteria, classification and treatment for Diogenes syndrome. The creation of a disease entity would enable earlier diagnosis and help patients.
- Open Access
- 12 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 58, 176-190
Medical cannabis: Mechanisms of action and therapeutic targets
Introduction: In recent years, multiple publications underscored many beneficial properties associated with medical marihuana. Its current applications encompass pain relief, multiple sclerosis, the treatment of anxiety disorders, Dravet syndrome and other. It can potentially extent to the treatment of patients with fibromyalgia or in people with diabetic complications. The expansive potential of medical cannabis in the prevention and treatment of many diseases is seen in its complex and multidirectional mechanisms of action. Medical marihuana has impact on cannabinoid receptors, and it exerts effects through many other molecular targets. Aim of the study: This review seeks present mechanisms of action of medical marihuana and explore its potential therapeutic targets. Materials and methods: A comprehensive review of literature available in the PubMed and Google Scholar databases was performed, using the following keywords: "medical marihuana", "medical cannabis", "medical marihuana mechanism of action", "therapeutic targets of medical marihuana", "endocannabinoid system", “medical marihuana in pain treatment”, “medical marihuana amygdala body”, “medical marihuana serotonin receptors”. Conclusions: Medical marihuana emerges as a promising candidate in the treatment of many diseases and common condition. However, further research is imperative to ascertain the effects of the drug and transform it into an effective medication which maximizes benefits and minimalizes side effects.
- 12 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 58, 176-190
Open AccessMedical cannabis: Mechanisms of action and therapeutic targets
Introduction: In recent years, multiple publications underscored many beneficial properties associated with medical marihuana. Its current applications encompass pain relief, multiple sclerosis, the treatment of anxiety disorders, Dravet syndrome and other. It can potentially extent to the treatment of patients with fibromyalgia or in people with diabetic complications. The expansive potential of medical cannabis in the prevention and treatment of many diseases is seen in its complex and multidirectional mechanisms of action. Medical marihuana has impact on cannabinoid receptors, and it exerts effects through many other molecular targets. Aim of the study: This review seeks present mechanisms of action of medical marihuana and explore its potential therapeutic targets. Materials and methods: A comprehensive review of literature available in the PubMed and Google Scholar databases was performed, using the following keywords: "medical marihuana", "medical cannabis", "medical marihuana mechanism of action", "therapeutic targets of medical marihuana", "endocannabinoid system", “medical marihuana in pain treatment”, “medical marihuana amygdala body”, “medical marihuana serotonin receptors”. Conclusions: Medical marihuana emerges as a promising candidate in the treatment of many diseases and common condition. However, further research is imperative to ascertain the effects of the drug and transform it into an effective medication which maximizes benefits and minimalizes side effects.
- Open Access
- 13 October 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 48 (1) , 105-113
Clinical differentiation between ovarian granulosa cell tumor and ovarian cancer: a review
Differentiation of granulosa cell tumor and ovarian cancer doesn’t seem to cause much trouble in everyday clinical work. Despite quite easy distinction, within the researches discussed within this review, findings were suggesting less obvious results. There was a huge urge to take into consideration immunohistochemical differentiation. Common symptoms of many gynecological tumors are very similar, studies investigated that GCT and ovarian cancer frequently overlap. Symptoms, method of treatment and prevalence rate (at some point) are often shared between these neoplasms. Fortunately, great distinction was provided by immunohistochemical findings.
- 13 October 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 48 (1) , 105-113
Open AccessClinical differentiation between ovarian granulosa cell tumor and ovarian cancer: a review
Differentiation of granulosa cell tumor and ovarian cancer doesn’t seem to cause much trouble in everyday clinical work. Despite quite easy distinction, within the researches discussed within this review, findings were suggesting less obvious results. There was a huge urge to take into consideration immunohistochemical differentiation. Common symptoms of many gynecological tumors are very similar, studies investigated that GCT and ovarian cancer frequently overlap. Symptoms, method of treatment and prevalence rate (at some point) are often shared between these neoplasms. Fortunately, great distinction was provided by immunohistochemical findings.
- Open Access
- 13 June 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 39 (1) , 160-174
The growing importance of high-efficiency ultrasound in diagnosis and management of dermatological diseases
Introduction: High-frequency ultrasonography (HF-USG) uses frequency above 20 MHz, which allows to visualize skin layers and measure their thickness. As it is simple, non-invasive and reliable technique, it has become a relevant tool in the field of dermatology along with other methods like for example dermoscopy. It can be used not only for the evaluation, diagnosis and management of various skin diseases, but also for analysis of the healthy skin structure Aim of the study: The aim of this review is to present information on the use of high-efficiency USG and its application in dermatology. Materials and methods: The literature available in the PubMed and Google Scholar data bases was reviewed, using the following keywords: "dermatologic ultrasound", "skin ultrasound, "HFUS dermatology". Conclusions: HFUS has given many opportunities in dermatology. Although ultrasound is not a new thing and it has been used in the field of dermatology for more than four decades, its significance has evolved with improvements in technology. We already have some pathognomonic sonographic features for skin lesions, but this amount will definitely increase due to the growing popularity of HFUS devices in clinical practice.
- 13 June 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 39 (1) , 160-174
Open AccessThe growing importance of high-efficiency ultrasound in diagnosis and management of dermatological diseases
Introduction: High-frequency ultrasonography (HF-USG) uses frequency above 20 MHz, which allows to visualize skin layers and measure their thickness. As it is simple, non-invasive and reliable technique, it has become a relevant tool in the field of dermatology along with other methods like for example dermoscopy. It can be used not only for the evaluation, diagnosis and management of various skin diseases, but also for analysis of the healthy skin structure Aim of the study: The aim of this review is to present information on the use of high-efficiency USG and its application in dermatology. Materials and methods: The literature available in the PubMed and Google Scholar data bases was reviewed, using the following keywords: "dermatologic ultrasound", "skin ultrasound, "HFUS dermatology". Conclusions: HFUS has given many opportunities in dermatology. Although ultrasound is not a new thing and it has been used in the field of dermatology for more than four decades, its significance has evolved with improvements in technology. We already have some pathognomonic sonographic features for skin lesions, but this amount will definitely increase due to the growing popularity of HFUS devices in clinical practice.
- Open Access
- 6 June 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 38 (1) , 294-308
Cannabidiol: main mechanisms of action and therapeutic targets
Introduction: Over the past few years, multiple publications have proven many beneficial properties associated with CBD. Currently, its use in the treatment of inflammatory and autoimmune diseases is suggested. Also, very often the use of CBD in the treatment of anxiety disorders, schizophrenia and depression, as well as Parkinson's disease and Alzheimer's disease is the subject of scientific research. CBD could be also used in treatment of the chronic pain in cancer patients or in people with diabetic complications. So far, it has been proven that CBD has anti-inflammatory, anticonvulsant, antioxidant, anti-arthritic, procognitive, cardio- and neuroprotective effects. The potential of cannabidiol in the prevention and treatment of many diseases is seen in its complex and multidirectional mechanisms of action. CBD has low affinity for cannabinoid receptors and acts as an inverse agonist of type 2 cannabinoid receptors (CB2-R). Additionally, CBD exerts its effects through many other molecular targets. Aim of the study: The aim of this review is to present mechanisms of action of cannabidiol and its possible therapeutic targets. Materials and methods: The literature available in the PubMed and Google Scholar data bases was reviewed, using the following keywords: "cannabidiol", "CBD", "CBD's mechanism of action", "CBD therapeutic targets", "endocannabinoid system". Conclusions: Cannabidiol is a promising candidate in the treatment of many common diseases. Furthermore, research is needed to confirm its beneficial effects and turn it into an effective drug that supports therapy with other drugs.
- 6 June 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 38 (1) , 294-308
Open AccessCannabidiol: main mechanisms of action and therapeutic targets
Introduction: Over the past few years, multiple publications have proven many beneficial properties associated with CBD. Currently, its use in the treatment of inflammatory and autoimmune diseases is suggested. Also, very often the use of CBD in the treatment of anxiety disorders, schizophrenia and depression, as well as Parkinson's disease and Alzheimer's disease is the subject of scientific research. CBD could be also used in treatment of the chronic pain in cancer patients or in people with diabetic complications. So far, it has been proven that CBD has anti-inflammatory, anticonvulsant, antioxidant, anti-arthritic, procognitive, cardio- and neuroprotective effects. The potential of cannabidiol in the prevention and treatment of many diseases is seen in its complex and multidirectional mechanisms of action. CBD has low affinity for cannabinoid receptors and acts as an inverse agonist of type 2 cannabinoid receptors (CB2-R). Additionally, CBD exerts its effects through many other molecular targets. Aim of the study: The aim of this review is to present mechanisms of action of cannabidiol and its possible therapeutic targets. Materials and methods: The literature available in the PubMed and Google Scholar data bases was reviewed, using the following keywords: "cannabidiol", "CBD", "CBD's mechanism of action", "CBD therapeutic targets", "endocannabinoid system". Conclusions: Cannabidiol is a promising candidate in the treatment of many common diseases. Furthermore, research is needed to confirm its beneficial effects and turn it into an effective drug that supports therapy with other drugs.
- Open Access
- 6 June 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 38 (1) , 258-276
Cholelithiasis - current knowledge about one of the most common diseases of the digestive system
Introduction: Cholelithiasis is one of the most common diseases of the digestive system and thus the most common cause of hospitalization in gastroenterology. According to the European Association for the Study of the Liver (EASL), it affects up to 20% of the European population and about 10-20% of the Polish population, and the number of patients is constantly increasing. This may be related to the growing problem of obesity and the widespread use of ultrasonography. The disease is also becoming more common in children and adolescents. The costs of gallstone diagnosis and treatment cause a huge financial burden on the health care system. As such, it is a public health issue that deserves more attention. Aim of the study: The aim of this review is to present current and the most important information about cholelithiasis – to determine the association between prevention and cholelithiasis, describe diagnosis, treatment and complications. Materials and methods: The review was based on the analysis of materials collected in the „Pubmed” database, Google Scholar, European Society for the Study of the Liver guidelines (EASL), books and other scientific articles. The search was performer using the key words: „cholelithiasis”, „cholelithiasis treatment”, „cholelithiasis diet”, „gallstone disease”,” gallstones”, „cholelithiasis etiology”, „Biliary Colic” Summary: Cholelithiasis is currently the most common disease of the bile ducts. The increasing incidence of patients with gallstones should contribute to the increased interest in this disease.
- 6 June 2023
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 38 (1) , 258-276
Open AccessCholelithiasis - current knowledge about one of the most common diseases of the digestive system
Introduction: Cholelithiasis is one of the most common diseases of the digestive system and thus the most common cause of hospitalization in gastroenterology. According to the European Association for the Study of the Liver (EASL), it affects up to 20% of the European population and about 10-20% of the Polish population, and the number of patients is constantly increasing. This may be related to the growing problem of obesity and the widespread use of ultrasonography. The disease is also becoming more common in children and adolescents. The costs of gallstone diagnosis and treatment cause a huge financial burden on the health care system. As such, it is a public health issue that deserves more attention. Aim of the study: The aim of this review is to present current and the most important information about cholelithiasis – to determine the association between prevention and cholelithiasis, describe diagnosis, treatment and complications. Materials and methods: The review was based on the analysis of materials collected in the „Pubmed” database, Google Scholar, European Society for the Study of the Liver guidelines (EASL), books and other scientific articles. The search was performer using the key words: „cholelithiasis”, „cholelithiasis treatment”, „cholelithiasis diet”, „gallstone disease”,” gallstones”, „cholelithiasis etiology”, „Biliary Colic” Summary: Cholelithiasis is currently the most common disease of the bile ducts. The increasing incidence of patients with gallstones should contribute to the increased interest in this disease.